VancomycinQualityChecker
Vancomycin
Vancomycin Quality Checker — Glycopeptide Antibiotic (Ph. Eur., USP)
ℹ️ The utility checks assay, CDP-1, residual protein, endotoxins, sterility.
ℹ️ Does not use machine learning — rule-based logic only.
⚠️ CRITICAL! CDP-1 ≤3.0%. Residual protein ≤100 ppm. Endotoxins ≤0.5 EU/mg!
Usage:
VancomycinQualityChecker.exe → demo mode
VancomycinQualityChecker.exe input.csv output.json → evaluate data
Input format:
BatchNumber,Assay_Percent,Loss_On_Drying_Percent,CDP_1_Impurity_Percent,Related_Substances_Total_Percent,Residual_Protein_ppm,Chloride_Content_Percent,Sulfated_Ash_Percent,Heavy_Metals_ppm,SterilityTest,Bacterial_Endotoxins_EU_per_mg,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_Methanol_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
Example:
VAN-SUB-2026-001,98.0,3.5,1.2,2.5,20,5.0,0.1,10,0,0.2,50,100,10,5,0,0
— WHY IS THIS NEEDED?
Vancomycin — glycopeptide antibiotic for severe Gram-positive infections:
• Degradation Products: During storage or improper synthesis, a specific impurity CDP-1 (agglomerate or deglycosylated product) is formed. Its level is strictly controlled (≤3.0%).
• Residual Protein: As the drug is obtained by fermentation, it is critical to control residual host cell proteins (≤100 ppm) to avoid immunogenic reactions.
• Parenteral Administration: Drug is administered intravenously. Therefore, requirements for sterility, endotoxins (≤0.5 EU/mg), and microbiological purity are extremely high.
• Composition: Chloride content control is important to confirm vancomycin hydrochloride stoichiometry.
⚠️ CRITICAL:
• Potency (Assay): 90–105%
• Chloride: 4–6%
• CDP-1: ≤ 3.0% (Critical!)
• Total Related Substances: ≤ 5.0%
• Residual Protein: ≤ 100 ppm
• Loss on Drying: ≤ 5.0%
• Heavy Metals: ≤ 20 ppm
• Endotoxins: ≤ 0.5 EU/mg (Critical for injection)
• Sterility: No growth
• Microbiology: TAMC ≤ 100 CFU/g, TYMC ≤ 10 CFU/g
⚠️ Note: Utility focuses on specific parameters of fermentation-derived antibiotics (residual protein, specific degradation products like CDP-1) and strict pyrogen control for parenteral use.
input.csv
BatchNumber,Assay_Percent,Loss_On_Drying_Percent,CDP_1_Impurity_Percent,Related_Substances_Total_Percent,Residual_Protein_ppm,Chloride_Content_Percent,Sulfated_Ash_Percent,Heavy_Metals_ppm,SterilityTest,Bacterial_Endotoxins_EU_per_mg,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_Methanol_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected VAN-SUB-2026-001,98.0,3.5,1.2,2.5,20,5.0,0.1,10,0,0.2,50,100,10,5,0,0
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Vancomycin Quality Checker utility is used for Vancomycin. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Global API expansion
Tags: antibiotics, antivirals, API, biologics, endotoxins, essential medicines, global market, heavy metals, impurities, injectables, microbiology, oncology
2. Execution modes
VancomycinQualityChecker.exe → demo mode VancomycinQualityChecker.exe input.csv output.json → evaluate data
3. Key controlled areas
- assay / content
- purity and impurities
- residual solvents
- microbiology and pathogens
- heavy metals / elemental impurities
4. Domain limits and critical parameters
- ⚠️ CRITICAL! CDP-1 ≤3.0%. Residual protein ≤100 ppm. Endotoxins ≤0.5 EU/mg!
- Degradation Products: During storage or improper synthesis, a specific impurity CDP-1 (agglomerate or deglycosylated product) is formed. Its level is strictly controlled (≤3.0%).
- Residual Protein: As the drug is obtained by fermentation, it is critical to control residual host cell proteins (≤100 ppm) to avoid immunogenic reactions.
- Parenteral Administration: Drug is administered intravenously. Therefore, requirements for sterility, endotoxins (≤0.5 EU/mg), and microbiological purity are extremely high.
- ⚠️ CRITICAL:
- Potency (Assay): 90–105%
- Chloride: 4–6%
- CDP-1: ≤ 3.0% (Critical!)
- Total Related Substances: ≤ 5.0%
- Residual Protein: ≤ 100 ppm
- Loss on Drying: ≤ 5.0%
- Heavy Metals: ≤ 20 ppm
- Endotoxins: ≤ 0.5 EU/mg (Critical for injection)
- Sterility: No growth
- Microbiology: TAMC ≤ 100 CFU/g, TYMC ≤ 10 CFU/g
- ⚠️ Note: Utility focuses on specific parameters of fermentation-derived antibiotics (residual protein, specific degradation products like CDP-1) and strict pyrogen control for parenteral use.
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Vancomycin with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: assay / content, purity and impurities, residual solvents, microbiology and pathogens, heavy metals / elemental impurities. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | VAN-SUB-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | Assay_Percent | decimal | % | Assay % | 98.0 | numeric value; compared with assay/purity limit from specification or method |
| 3 | Loss_On_Drying_Percent | decimal | % | Loss On Drying % | 3.5 | mandatory numeric value; rule comparison is performed by the utility |
| 4 | CDP_1_Impurity_Percent | decimal | % | CDP 1 Impurity % | 1.2 | numeric value; compared with individual or total impurity limit |
| 5 | Related_Substances_Total_Percent | decimal | % | Related Substances Total % | 2.5 | numeric value; compared with individual or total impurity limit |
| 6 | Residual_Protein_ppm | decimal | ppm | Residual Protein ppm | 20 | mandatory numeric value; rule comparison is performed by the utility |
| 7 | Chloride_Content_Percent | decimal | % | Chloride Content % | 5.0 | numeric value; compared with assay/purity limit from specification or method |
| 8 | Sulfated_Ash_Percent | decimal | % | Sulfated Ash % | 0.1 | mandatory numeric value; rule comparison is performed by the utility |
| 9 | Heavy_Metals_ppm | decimal | ppm | Heavy Metals ppm | 10 | numeric value; checked as elemental/metal impurity |
| 10 | SterilityTest | boolean / flag | 0/1 | Sterility Test | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 11 | Bacterial_Endotoxins_EU_per_mg | decimal | EU/ml | Bacterial Endotoxins EU per mg | 0.2 | numeric value; critical safety attribute compared with endotoxin limit |
| 12 | Residual_Solvent_Acetonitrile_ppm | decimal | ppm | Residual Solvent Acetonitrile ppm | 50 | numeric value; checked as residual solvent against the applicable limit |
| 13 | Residual_Solvent_Methanol_ppm | decimal | ppm | Residual Solvent Methanol ppm | 100 | numeric value; checked as residual solvent against the applicable limit |
| 14 | Microbial_Count_TAMC | decimal | as specified | Microbial Count TAMC | 10 | numeric value; compared with microbiological limits |
| 15 | Microbial_Count_TYMC | decimal | as specified | Microbial Count TYMC | 5 | numeric value; compared with microbiological limits |
| 16 | EColi_Detected | boolean / flag | 0/1 | EColi Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 17 | Salmonella_Detected | boolean / flag | 0/1 | Salmonella Detected | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
CSV example
BatchNumber,Assay_Percent,Loss_On_Drying_Percent,CDP_1_Impurity_Percent,Related_Substances_Total_Percent,Residual_Protein_ppm,Chloride_Content_Percent,Sulfated_Ash_Percent,Heavy_Metals_ppm,SterilityTest,Bacterial_Endotoxins_EU_per_mg,Residual_Solvent_Acetonitrile_ppm,Residual_Solvent_Methanol_ppm,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected VAN-SUB-2026-001,98.0,3.5,1.2,2.5,20,5.0,0.1,10,0,0.2,50,100,10,5,0,0
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable VancomycinQualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Vancomycin, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "VancomycinQualityChecker",
"api": "Vancomycin",
"batchNumber": "VAN-SUB-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "VAN-SUB-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Assay_Percent",
"value": "98.0",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Loss_On_Drying_Percent",
"value": "3.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "CDP_1_Impurity_Percent",
"value": "1.2",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Related_Substances_Total_Percent",
"value": "2.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Residual_Protein_ppm",
"value": "20",
"unit": "ppm",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Chloride_Content_Percent",
"value": "5.0",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Sulfated_Ash_Percent",
"value": "0.1",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
| TC-007 | Residual solvent above applicable limit | FAIL is produced with solvent name and measured value. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Algeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenArgentina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenAustralia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBangladesh: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenBrazil: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenCanada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenChina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenColombia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenDemocratic Republic of the Congo: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEgypt: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenEthiopia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenFrance: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenGermany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIndia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenIndonesia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenInfectious Diseases QC Suite
QC utility package for infectious diseases: antibacterial, antiviral, antifungal and antiparasitic products, microbiology, sterility, endotoxins, viral safety and vaccine release checks.
OpenIran: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenItaly: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenJapan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenKenya: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMexico: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenMyanmar: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenNigeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPakistan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenPhilippines: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenRussia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSaudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Africa: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSouth Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenSudan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTanzania: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenThailand: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenTurkey: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUganda: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenUnited States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenVietnam: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
OpenWorld API Extension QC Suite
Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.
Open